Apalutamide Tablets

Product Description

Description: Oral anticancer medication containing apalutamide, used in the treatment of prostate cancer. It is designed to inhibit androgen receptor signaling involved in tumor growth.

Therapeutic Category: Antineoplastic / Hormonal Therapy / Targeted Therapy

Mechanism of Action (MOA): Apalutamide selectively binds to androgen receptors and blocks their activity, preventing androgen-mediated growth signals in prostate cancer cells.

This helps:
•Slow progression of prostate cancer
•Reduce tumor cell proliferation
•Delay metastasis development
•Improve disease control and patient outcomes

Swasthya Healthcare Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

Swasthya Healthcare Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Swasthya Healthcare Private Limited (30)

  • Ibrutinib Capsules 140 mg

    Product Ibrutinib Capsules 140 mg

    Description: Oral targeted anticancer medication containing ibrutinib, used in the treatment of various B-cell malignancies such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma.

    Therapeutic Category: Antineoplastic / Targeted Therapy

    ...
  • Deferasirox 250mg

    Product Deferasirox 250mg

    Description: Oral iron chelating agent used for the treatment of chronic iron overload caused by repeated blood transfusions. Available as film-coated or dispersible tablets.

    Therapeutic Category: Iron Chelator / Hematology

    Mechanism of Action (MOA): Deferasirox b...
  • Enoxaparin Sodium Injection USP 40 mg/0.4 ml

    Product Enoxaparin Sodium Injection USP 40 mg/0.4 ml

    Description: Sterile injectable solution containing enoxaparin sodium, a low molecular weight heparin (LMWH) used for prevention and treatment of blood clots. Administered subcutaneously or intravenously under medical supervision.

    Therapeutic Category: Antic...
  • Fingolimod 0.50mg Capsule

    Product Fingolimod 0.50mg Capsule

    Description: Oral immunomodulatory medication used primarily in the treatment of relapsing forms of multiple sclerosis. It helps reduce disease activity and progression.

    Therapeutic Category: Immunomodulator / Neurology

    Mechanism of Action (MOA): ...
  • Eltrombopag 25mg

    Product Eltrombopag 25mg

    Description: Oral medication containing eltrombopag, a thrombopoietin receptor agonist used to increase platelet production in patients with certain hematological conditions.

    Therapeutic Category: Thrombopoietin Receptor Agonist / Hematologic Agent
    ...
  • Pembrolizumab 100 mg/4 ml

    Product Pembrolizumab 100 mg/4 ml

    Description: Sterile injectable formulation of pembrolizumab, a monoclonal antibody used in immunotherapy. It enhances the body’s immune response against tumor cells by targeting immune checkpoint pathways. Commonly used in the treatment of various cancers, including melanoma, lung cancer, and other advan...
  • Venetoclax Tablets 100 mg

    Product Venetoclax Tablets 100 mg

    Description: Oral targeted anticancer medication containing venetoclax, primarily used in the treatment of certain hematological malignancies such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).

    Therapeutic Category: Antineoplastic / Targeted Therapy...
  • Acalabrutinib Capsule 100 mg

    Product Acalabrutinib Capsule 100 mg

    Description: Oral capsule formulation of acalabrutinib, a selective Bruton’s tyrosine kinase (BTK) inhibitor. It is designed to interfere with B-cell receptor signaling, thereby reducing the growth and survival of malignant B-cells. Commonly used in the treatment of certain hematological malignancies.
    ...
  • Fulvestrant  Injectable Solution 250 mg/5 ml

    Product Fulvestrant Injectable Solution 250 mg/5 ml

    Description: Sterile oily injectable solution containing fulvestrant, an estrogen receptor antagonist used in the treatment of hormone receptor-positive breast cancer. Administered via intramuscular injection.

    Therapeutic Category: Antineoplastic / Hormonal Therapy
    ...
  • Conjugated Estrogen Vaginal Cream

    Product Conjugated Estrogen Vaginal Cream

    Description:
    Topical hormonal formulation containing conjugated estrogens, specially designed to relieve symptoms associated with vaginal atrophy and estrogen deficiency during menopause. Provides localized estrogen therapy with targeted comfort and restoration.

    Therapeutic Category: Hormonal T...
  • Mirogabalin Besylate

    Product Mirogabalin Besylate

    Description: Oral neuropathic pain management therapy containing mirogabalin besylate, developed to provide targeted relief in peripheral neuropathic pain conditions. Designed for effective symptom control with improved patient tolerability.

    Therapeutic Category: Neurology ...
  • Goserelin Acetate PFS 3.6 mg

    Product Goserelin Acetate PFS 3.6 mg

    Description: Sterile depot formulation of goserelin acetate supplied in a pre-filled syringe for subcutaneous implantation. It is a long-acting gonadotropin-releasing hormone (GnRH) agonist designed for sustained suppression of sex hormone production with extended-release dosing, typically administered on...

Swasthya Healthcare Private Limited resources (2)

  • Brochure SWASTHYA HEALTHCARE PRESENTATION

    Swasthya Healthcare is an integrated pharmaceutical company from India & has offices in UAE, Singapore, and Guatemala with a strong presence across Latin America, including El Salvador, Guatemala, Bolivia, and Nicaragua. We specialize in a wide range of product categories including Oncology, Antiretrovirals (ARVs), Contrast Media, and Critical Care products.

  • Brochure CONTRAST MEDIA PRESENTATION

    Swasthya Healthcare--CONTRAST MEDIA PRODUCT RANGE